Literature DB >> 10884258

Orlistat associated with hypertension.

M Persson1, S Vitols, Q Y Yue.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10884258      PMCID： PMC27428     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

1.  The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia.

Authors:  S Tonstad; D Pometta; D W Erkelens; L Ose; T Moccetti; J A Schouten; A Golay; J Reitsma; A Del Bufalo; E Pasotti
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953
  1 in total
  4 in total

1.  Orlistat associated with hypertension. Digit preference lays conclusions about orlistat open to doubt.

Authors:  G D Johnston
Journal:  BMJ       Date:  2001-01-13

Review 2.  Orlistat-associated adverse effects and drug interactions: a critical review.

Authors:  Theodosios D Filippatos; Christos S Derdemezis; Irene F Gazi; Eleni S Nakou; Dimitri P Mikhailidis; Moses S Elisaf
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 3.  Benefit-risk assessment of orlistat in the treatment of obesity.

Authors:  Priya Sumithran; Joseph Proietto
Journal:  Drug Saf       Date:  2014-08       Impact factor: 5.606

Review 4.  Safety of drug therapies used for weight loss and treatment of obesity.

Authors:  Lisa L Ioannides-Demos; Joseph Proietto; Andrew M Tonkin; John J McNeil
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.